How RT3 Buccal Delivery Is Compared With Other Delivery Forms in Peptide Research

RT3 buccal delivery is compared in peptide research with injection, with swallowing, and with other mucosal routes, by measuring how much retatrutide is absorbed, how fast, and how much is lost, for each route, in the same model, with the same measures.

Delivery is a comparison, not a claim. For an overview of the buccal film, see Retatrutide buccal strips research.

This article on how RT3 buccal delivery is compared with other delivery forms in peptide research is presented as research material only. It does not diagnose, treat, cure, or prevent any disease, does not recommend use in people, and does not present buccal strips as an approved drug or supplement for human consumption.

Buccal Delivery, in Brief

Buccal delivery is delivery through the lining of the mouth. A film is placed in the mouth, where it dissolves, and its contents are absorbed through the oral mucosa, rather than through the digestive tract. That route is studied for peptides because peptides are normally broken down in the gut, and swallowing a peptide does not establish the same exposure as buccal absorption.

The RT3 film contains 1mg of retatrutide per film, with 8 films in a box. The film is a rapid-release oral dissolving strip, made to dissolve in the mouth. That description is a product description, not a delivery result. A delivery result needs an absorption measure, for that film, in that model.

Injection, as a Comparison

Injection is the comparison route for retatrutide, because human retatrutide evidence comes from injected retatrutide, in Phase 2 studies and in the TRIUMPH Phase 3 programme, which are covered in Retatrutide research. Injection gives a known systemic exposure, with a stated amount, a stated route, and a stated measure.

A buccal film result should not be read as if it were an injection result, unless buccal exposure was actually measured, in the same model, with the same measures, and compared with injection exposure. A delivery route can change exposure without changing the compound, and exposure must be measured before any metabolic reading is made.

That comparison is about delivery, not about effect. A route that gives lower exposure does not mean a compound does not work, and a route that gives higher exposure does not mean a compound works better. It means the exposure was different, and the metabolic reading must be made for that exposure, not for another route.

Swallowing, as a Comparison

Swallowing is the other comparison route, because a peptide that is swallowed is normally broken down in the gut, and does not reach the blood in the same form, or in the same amount, as a peptide that is absorbed through the mouth lining.

Buccal delivery is studied as a way to avoid that gut breakdown, in part. It is not studied as a way to avoid it completely, because some of a film is swallowed, with saliva, and some is lost in the mouth. That loss is called swallowing loss, and it is a delivery measure, not an assumption.

A buccal delivery study must therefore report, for each route, how much was absorbed, how fast, and how much was lost, in the same model, with the same measures. A study that reports only buccal delivery, without a swallowing comparison, has reported a buccal result, not a buccal comparison.

Other Mucosal Routes

Other mucosal routes, such as sublingual delivery, under the tongue, and intranasal delivery, through the nose, are also studied for peptides, for the same reason: to avoid gut breakdown, in part. Those routes are not the same as buccal delivery, and they should not be read as if they were.

Buccal delivery is through the cheek lining, sublingual delivery is under the tongue, and intranasal delivery is through the nose. Each route has a different surface, a different blood flow, and a different loss, and each route must be measured separately, in the same model, with the same measures, before a comparison is made.

External Evidence

Buccal peptide delivery literature, as reviewed for this article, is centred on dissolution, mucosal permeation in vitro, swallowing loss, and systemic exposure in animal models, with injection as a comparison route, and swallowing as a comparison route, in laboratory and animal models.

Retatrutide delivery literature, as reviewed for this article, is centred on injected retatrutide, in Phase 2 and TRIUMPH Phase 3 studies, and should be read as such. No published human buccal pharmacokinetic study for retatrutide was found that compared buccal delivery with injection, or with swallowing, for exposure, in people.

What RT3 Buccal Delivery Research Can Establish

• How buccal delivery is measured, for a peptide film, in vitro and in animal models, for absorption, speed, and loss.
• How buccal exposure compares with injection exposure, in the same model, with the same measures.
• How buccal exposure compares with swallowing exposure, in the same model, with the same measures.
• Whether a buccal film result can be read for exposure, or only for dissolution, in the model actually used.

What RT3 Buccal Delivery Research Does Not Establish

• That a buccal film result is the same as an injection result, without a buccal pharmacokinetic study in people.
• That a buccal film improves appetite regulation, energy balance, metabolic rate, fat metabolism, or body composition in people.
• That a buccal delivery result in one model, with one measure, applies to another model, another measure, or another route.
• That a buccal strip is an approved drug or supplement for human use.

Final Perspective

Buccal delivery is a comparison question, and it must be answered with a comparison design. A film that dissolves well has shown dissolution, not delivery, and a film that is absorbed in one model has shown absorption in that model, not in every model, and not in people, unless that study was actually done.

For how RT3 buccal absorption is studied in peptide research, see how RT3 buccal absorption is studied in peptide research.

Related product: RT3 Buccal Strips 1mg, 8 count, research material. Details on the product page.